About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

COMPLETEDNA

Study to Evaluate Safety and Efficacy of GrafixPL for the Treatment of Venous Leg Ulcers

A Multicenter, Prospective, Randomized, Open-Label Study With a Crossover Extension Option to Evaluate the Safety and Efficacy of GrafixPL for the Treatment of Chronic Venous Leg Ulcers

NCT03629236•Osiris Therapeutics

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Venous Leg Ulcer

Interventions

GrafixPL

Control

Locations

2

United States

Locations (2)

Integral Clinical Trial Solutions

Doral, Florida, United States

SSH

Weymouth, Massachusetts, United States

Key Dates

Start Date

June 27, 2018

Primary Completion Date

June 24, 2021

Completion Date

June 24, 2021

Last Updated

April 12, 2022

Related Studies

Non-healing Venous Leg Ulcers Treated With Standard Care With or Without BR-AC

NCT06811909

Non-infected Venous Leg UlcerVenous Leg Ulcer+3 more

The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study

NCT05489588

Venous ThrombosesVenous Disease+8 more

INNOVEN: Efficacy of Porcine Placental Extracellular Matrix Plus Standard of Care (SOC) Versus SOC Alone

NCT06606210

Wound HealVenous Leg Ulcer

Human Amniotic Membrane On Venous Leg Ulcers In an Elderly Population

NCT06544564

Venous Leg Ulcer

RECRUITINGPhase 1/2

A Study of XSTEM-VLU in Patients With Difficult-to-heal Venous Leg Ulcers

NCT05549609

Venous Leg Ulcer

Finnish Venous Ulcer Study (FINNULCER Study)

NCT04737941

Venous Leg Ulcer

View all related studies

Sponsors

Lead Sponsor

Osiris Therapeutics

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 12, 2022Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions